Skip to content
IBEX

IBEX Limited

IBEX Limited Q2 FY2026 earnings call

February 6, 2026 · fiscal period ended 2025-12

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2026-02-06

Management highlights

  • Recognized the IBEX organization for delivering an outstanding quarter with headline revenue growth of 17% and adjusted EPS growth of 46%.
  • Fourth consecutive period of double-digit organic revenue growth. HealthTech vertical growing rapidly, on track to be $100M by end of fiscal year.
  • Expansion into India with 2 sites and nearly 1,000 agents, offering broader services beyond traditional contact center.
  • Achieved milestones in 2025: surpassed $600M in revenue, grew 16% profitably with $80M EBITDA and 13% margins.
  • Market-leading growth due to differentiation, new logo engine winning trophy clients in HealthTech and FinTech.
  • AI capabilities with Wave iX solution, leveraging business insights and internal AI deployment for efficiency.
  • Promoted Mike Darwal to Chief AI and Digital Officer.
View in transcript ↓

Segment performance

In the second quarter of FY 2026, IBEX achieved headline revenue growth of 17% and adjusted EPS growth of 46%. Revenue breakdown by verticals: HealthTech increased to 17.4% of revenue from 15.1% prior year, Travel, transportation and logistics to 14.1% from 13.7%, Retail and e-commerce remained 28.6%, Other increased to 13.7% from 10.6%, FinTech was 9.3% (relatively flat), and Telecommunications decreased to 8.7% from 13.1%. Geographically, offshore revenues comprised 52.3% of total revenue, onshore revenues expanded to 24% from 22% prior year, nearshore grew 8.5%, and higher-margin digital and omnichannel services grew 19% to 82% of total revenue.

View in transcript ↓

Guidance

  • Revenue expected to be in the range of $620 million to $630 million, up from previous range of $605 million to $620 million.
  • Adjusted EBITDA expected to be in the range of $80 million to $82 million, up from previous range of $78 million to $81 million.
  • Capital expenditures expected to be at the upper end of the previous $20 million to $25 million range.
View in transcript ↓

Risks

  • Deferred training revenue impact during high-growth phase as training costs are expensed in period but revenue is spread over the program.
  • Investment in India still ongoing with margins not yet fully realized as it's less than a year since expansion.
View in transcript ↓

Q&A highlights

Q: A lot of market turbulence around AI and who's going to win and who's going to lose and new products coming out. Is your industry and your company a benefit of AI? Is it a headwind?

A: Yes, we've established AI leadership position. Helps new logo engine win BPO deals, aids operational execution to distance from pack, and creates unique AI agentic solutions with seamless end-to-end journey.

Q: The mix of business is changing, does that change the sequential pattern of revenue? And the gross margins went down year-over-year, but operating expense percent of revenue got more favorable. What's driving that?

A: Mix change leads to less massive spike in Q2 historically. SG&A expenses are growing less than revenue, so SG&A as percent of revenue is decreasing. Headwinds include deferred training revenue impact and investment in India still affecting margins but are due to growth.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

February 6, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.